 recommendation: Grade 1 (Strong), Quality of Evidence: B (Moderate)
Recommendation 15: We suggest TEVAR in selected
cases of asymptomatic penetrating aortic ulcer in patients who have at-risk characteristics for growth or
rupture. Level of recommendation: Grade 2 (Weak),
Quality of Evidence: B (Moderate)
Recommendation 16: We suggest TEVAR for symptomatic mycotic/infected TAA as a temporizing measure, but
